关注
Gang Meng
Gang Meng
在 smail.nju.edu.cn 的电子邮件经过验证
标题
引用次数
引用次数
年份
Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
B Li, Y Cao, G Meng, L Qian, T Xu, C Yan, O Luo, S Wang, J Wei, Y Ding, ...
EBioMedicine 39, 239-254, 2019
1882019
Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
D Yu, X Shi, G Meng, J Chen, C Yan, Y Jiang, J Wei, Y Ding
Oncotarget 6 (10), 7619, 2015
1662015
Mitophagy enhances oncolytic measles virus replication by mitigating DDX58/RIG-I-like receptor signaling
M Xia, P Gonzalez, C Li, G Meng, A Jiang, H Wang, Q Gao, KM Debatin, ...
Journal of virology 88 (9), 5152-5164, 2014
1282014
Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells
G Meng, M Xia, D Wang, A Chen, Y Wang, H Wang, D Yu, J Wei
Oncotarget 5 (15), 6365, 2014
662014
Oncolytic measles virus enhances antitumour responses of adoptive CD8+ NKG2D+ cells in hepatocellular carcinoma treatment
A Chen, Y Zhang, G Meng, D Jiang, H Zhang, M Zheng, M Xia, A Jiang, ...
Scientific reports 7 (1), 5170, 2017
602017
Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
G Meng, B Li, A Chen, M Zheng, T Xu, H Zhang, J Dong, J Wu, D Yu, ...
British Journal of Cancer 122 (1), 111-120, 2020
572020
The glutaminase-1 inhibitor 968 enhances dihydroartemisinin-mediated antitumor efficacy in hepatocellular carcinoma cells
D Wang, G Meng, M Zheng, Y Zhang, A Chen, J Wu, J Wei
PLoS One 11 (11), e0166423, 2016
462016
Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus
M Xia, G Meng, A Jiang, A Chen, M Dahlhaus, P Gonzalez, C Beltinger, ...
Oncotarget 5 (11), 3907, 2014
462014
Multifunctional antitumor molecule 5′‐triphosphate siRNA combining glutaminase silencing and RIG‐I activation
G Meng, M Xia, C Xu, D Yuan, M Schnurr, J Wei
International journal of cancer 134 (8), 1958-1971, 2014
442014
Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy
M Xia, D Luo, J Dong, M Zheng, G Meng, J Wu, J Wei
Journal of Experimental & Clinical Cancer Research 38, 1-16, 2019
432019
Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma
C Li, G Meng, L Su, A Chen, M Xia, C Xu, D Yu, A Jiang, J Wei
Oncotarget 6 (3), 1544, 2014
402014
GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors
Y Li, B Li, Y Xu, L Qian, T Xu, G Meng, H Li, Y Wang, L Zhang, X Jiang, ...
Cancer Research 82 (18), 3223-3235, 2022
382022
Anti-angiogenic efficacy of 5′-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs
D Yuan, M Xia, G Meng, C Xu, Y Song, J Wei
Oncotarget 6 (30), 29664, 2015
302015
Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT)
S Zuo, M Wei, B He, A Chen, S Wang, L Kong, Y Zhang, G Meng, T Xu, ...
EBioMedicine 64, 2021
272021
CD8+ T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma
C Xu, X Lu, W Liu, A Chen, G Meng, H Zhang, B Li, Y Zhang, J Wu, J Wei
Journal of Translational Medicine 16, 1-12, 2018
202018
Revealing chemical processes and kinetics of drug action within single living cells via plasmonic Raman probes
SS Li, QY Guan, G Meng, XF Chang, JW Wei, P Wang, B Kang, JJ Xu, ...
Scientific Reports 7 (1), 2296, 2017
202017
Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model
L Su, H Zhang, C Yan, A Chen, G Meng, J Wei, D Yu, Y Ding
Oncotarget 7 (40), 65721, 2016
172016
Photoacoustic “nanobombs” fight against undesirable vesicular compartmentalization of anticancer drugs
A Chen, C Xu, M Li, H Zhang, D Wang, M Xia, G Meng, B Kang, H Chen, ...
Scientific Reports 5 (1), 15527, 2015
172015
Liver-enriched genes are associated with the prognosis of patients with hepatocellular carcinoma
B Li, T Xu, C Liu, G Meng, Y Sun, L Qian, S Wang, J Wei, D Yu, Y Ding
Scientific reports 8 (1), 11197, 2018
162018
Fludarabine as an adjuvant improves Newcastle Disease Virus-mediated antitumor immunity in hepatocellular carcinoma
G Meng, Z Fei, M Fang, B Li, A Chen, C Xu, M Xia, D Yu, J Wei
Molecular Therapy-Oncolytics 13, 22-34, 2019
152019
系统目前无法执行此操作,请稍后再试。
文章 1–20